Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Trop2-targeted immunoPET Imaging of Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Ovarian Cancer Identification on CT Using Deep Learning
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
- Status
- COMPLETED
- Phase
- PHASE1
ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients
- Status
- RECRUITING
- Phase
- N/A
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
- Status
- RECRUITING
- Phase
- N/A
A Study of PHST001 in Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression
- Status
- RECRUITING
- Phase
- PHASE2
Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario
- Status
- RECRUITING
- Phase
- N/A
A Study of SHR-A1811 in Subjects With Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- Status
- RECRUITING
- Phase
- PHASE3
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Status
- RECRUITING
- Phase
- PHASE3
Ovarian Cancer Radiomics Approach in CT Led Evaluation
- Status
- RECRUITING
- Phase
- N/A
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
- Status
- RECRUITING
- Phase
- N/A
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
The Impact of the Inflammation Index on Predicting Postoperative Complications in Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A